Neogen Chemicals Ltd is Rated Hold by MarketsMOJO

4 hours ago
share
Share Via
Neogen Chemicals Ltd is rated 'Hold' by MarketsMojo, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Neogen Chemicals Ltd is Rated Hold by MarketsMOJO

Rating Overview and Context

On 25 May 2026, MarketsMOJO revised Neogen Chemicals Ltd’s rating from 'Sell' to 'Hold', reflecting an improvement in the company’s overall assessment. The Mojo Score increased by 8 points, moving from 42 to 50, signalling a more balanced outlook. This 'Hold' rating suggests that investors should maintain their current positions rather than aggressively buying or selling, as the stock exhibits a mix of strengths and weaknesses.

It is important to note that while the rating change occurred on 25 May 2026, all financial data, returns, and fundamental indicators referenced below are as of 08 June 2026. This ensures that the evaluation is based on the most recent information available, allowing investors to make informed decisions grounded in the current market environment.

Quality Assessment

Neogen Chemicals currently holds an average quality grade. The company’s ability to generate returns on equity remains modest, with an average Return on Equity (ROE) of 6.86%, indicating relatively low profitability per unit of shareholders’ funds. Furthermore, the company’s operating profit has grown at an annualised rate of 13.82% over the past five years, which is moderate but not indicative of robust expansion.

However, the company’s financial health raises concerns. The Debt to EBITDA ratio stands at a high 10.16 times, signalling a significant debt burden relative to earnings before interest, taxes, depreciation, and amortisation. This elevated leverage constrains the company’s flexibility and increases financial risk, particularly in a volatile economic environment.

Valuation Considerations

From a valuation perspective, Neogen Chemicals is currently classified as very expensive. The stock trades at an enterprise value to capital employed (EV/CE) ratio of 3, which is high relative to its returns and peers. Despite this, the stock is trading at a discount compared to the average historical valuations of its sector peers, suggesting some relative value remains for investors willing to accept the risks.

It is worth noting that the company’s Return on Capital Employed (ROCE) is low at 5.25% for the half-year period, which does not justify a premium valuation. Investors should be cautious, as the expensive valuation combined with weak returns may limit upside potential in the near term.

Financial Trend and Profitability

The financial trend for Neogen Chemicals is currently negative. The company has reported losses for four consecutive quarters, reflecting operational challenges. Profit After Tax (PAT) for the latest six months stands at ₹15.08 crores, having declined by 30.32% compared to previous periods. Meanwhile, interest expenses have increased by 33.69% to ₹42.98 crores, further pressuring profitability.

Over the past year, the stock has delivered a total return of 15.27%, but this has been accompanied by a 34.9% decline in profits, highlighting a disconnect between market performance and underlying earnings. Such a trend warrants caution, as sustained profit erosion could weigh on future stock performance.

Technical Outlook

Technically, Neogen Chemicals exhibits a bullish trend. The stock has shown strong momentum over recent months, with returns of +7.34% in the past month and an impressive +89.42% over six months. Year-to-date gains stand at 60.83%, reflecting positive investor sentiment and buying interest.

Despite the fundamental challenges, the bullish technical grade suggests that market participants are optimistic about the stock’s near-term prospects. This divergence between technical strength and fundamental weakness is not uncommon in smallcap specialty chemical stocks, where market sentiment can drive price action independently of earnings.

Here's How the Stock Looks Today

As of 08 June 2026, Neogen Chemicals Ltd presents a mixed picture for investors. The company’s average quality and negative financial trend are offset somewhat by bullish technicals and a valuation that, while expensive, is not extreme relative to peers. The 'Hold' rating reflects this balance, advising investors to maintain their current holdings while monitoring developments closely.

Investors should be mindful of the company’s high debt levels and declining profitability, which pose risks to long-term growth and shareholder returns. At the same time, the stock’s recent price momentum may offer trading opportunities for those with a higher risk tolerance.

This week's disclosed pick, a Large Cap from NBFC, comes with precise Target Price and analysis. Check if you're positioned right for this opportunity!

  • - Precise target price set
  • - Weekly selection live
  • - Position check opportunity

Check Your Position →

Investor Takeaway

For investors, the 'Hold' rating on Neogen Chemicals Ltd indicates a cautious stance. The company’s current fundamentals do not support a strong buy recommendation, given the high debt, negative profit trends, and expensive valuation. However, the bullish technical signals and recent stock price gains suggest that the market sees potential for recovery or positive catalysts ahead.

Investors should closely monitor upcoming quarterly results and debt servicing metrics to assess whether the company can stabilise its earnings and improve financial health. Those with a medium to long-term horizon may consider holding the stock while watching for signs of operational turnaround. Conversely, risk-averse investors might prefer to wait for clearer improvements before increasing exposure.

In summary, Neogen Chemicals Ltd’s 'Hold' rating reflects a balanced view that recognises both the risks and opportunities inherent in the stock as of 08 June 2026. This nuanced perspective helps investors align their portfolio strategies with the company’s current market position and outlook.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News